Iron Triangle Partners LP's Q1 2023 13F: 12 new positions, 11 exits
Form 13F-HR for the quarter ended Mar 31, 2023 · filed May 15, 2023 · 27 reported positions · accession 0001172661-23-002176
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| Exited | UNIVERSAL HLTH SVCS INC (UHS) | 7.6% | — | −7.6 pts | −300K sh | −100% |
| New | ABBVIE INC (ABBV) | — | 7.4% | +7.4 pts | +320K sh | new |
| New | UNITEDHEALTH GROUP INC (UNH) | — | 5.5% | +5.5 pts | +80,000 sh | new |
| Exited | REPLIGEN CORP (RGEN) | 5.4% | — | −5.4 pts | −178K sh | −100% |
| Exited | BOSTON SCIENTIFIC CORP (BSX) | 5.0% | — | −5.0 pts | −600K sh | −100% |
| New | EVOLENT HEALTH INC (EVH) | — | 4.7% | +4.7 pts | +1M sh | new |
| Increased | SANOFI (SNY) | 5.6% | 9.3% | +3.6 pts | +530K sh | +81% |
| Increased | DEXCOM INC (DXCM) | 2.4% | 5.7% | +3.3 pts | +220K sh | +183% |
| New | IDEXX LABS INC (IDXX) | — | 3.6% | +3.6 pts | +50,000 sh | new |
| Exited | UNITED THERAPEUTICS CORP DEL (UTHR) | 3.6% | — | −3.6 pts | −71,576 sh | −100% |
| Exited | CIGNA CORP NEW (CI) | 3.6% | — | −3.6 pts | −60,000 sh | −100% |
| New | LEGEND BIOTECH CORP (LEGN) | — | 3.5% | +3.5 pts | +500K sh | new |
| Increased | ACADIA HEALTHCARE COMPANY IN (ACHC) | 3.0% | 5.3% | +2.4 pts | +313K sh | +156% |
| New | 10X GENOMICS INC (TXG) | — | 2.8% | +2.8 pts | +350K sh | new |
| Reduced | SURGERY PARTNERS INC (SGRY) | 6.4% | 4.1% | −2.3 pts | −464K sh | −36% |
| New | SCHRODINGER INC (SDGR) | — | 2.3% | +2.3 pts | +596K sh | new |
| Exited | INARI MED INC (NARI) | 2.2% | — | −2.2 pts | −190K sh | −100% |
| Exited | NEUROCRINE BIOSCIENCES INC (NBIX) | 2.1% | — | −2.1 pts | −100K sh | −100% |
| Reduced | COOPER COS INC (COO) | 7.3% | 4.6% | −2.7 pts | −38,000 sh | −31% |
| New | CUTERA INC (CUTRQ) | — | 2.0% | +2.0 pts | +600K sh | new |
| Reduced | CHARLES RIV LABS INTL INC (CRL) | 7.8% | 3.8% | −4.0 pts | −70,000 sh | −35% |
| Increased | INTUITIVE SURGICAL INC (ISRG) | 3.3% | 4.4% | +1.1 pts | +50,000 sh | +71% |
| Exited | SYNDAX PHARMACEUTICALS INC (SNDX) | 1.7% | — | −1.7 pts | −370K sh | −100% |
| Exited | AMYLYX PHARMACEUTICALS INC (AMLX) | 1.6% | — | −1.6 pts | −240K sh | −100% |
| Exited | PROMETHEUS BIOSCIENCES INC (RXDX) | 1.5% | — | −1.5 pts | −75,000 sh | −100% |
| New | OLINK HLDG AB (OLK) | — | 1.3% | +1.3 pts | +400K sh | new |
| New | 2SEVENTY BIO INC (TSVT) | — | 1.3% | +1.3 pts | +869K sh | new |
| Exited | KARYOPHARM THERAPEUTICS INC (KPTI) | 1.2% | — | −1.2 pts | −1.93M sh | −100% |
| New | SPRINGWORKS THERAPEUTICS INC (SWTX) | — | 1.2% | +1.2 pts | +313K sh | new |
| New | BROOKDALE SR LIVING INC (BKD) | — | 1.1% | +1.1 pts | +2.7M sh | new |
| Reduced | ICON PLC (ICLR) | 7.8% | 5.9% | −2.0 pts | −35,000 sh | −16% |
| Increased | SAREPTA THERAPEUTICS INC (SRPT) | 2.5% | 3.2% | +0.7 pts | +52,251 sh | +48% |
| Increased | PACIFIC BIOSCIENCES CALIF IN (PACB) | 2.5% | 3.8% | +1.3 pts | +600K sh | +35% |
| Increased | GILEAD SCIENCES INC (GILD) | 5.7% | 5.0% | −0.7 pts | +46,431 sh | +12% |
| Reduced | INSPIRE MED SYS INC (INSP) | 3.6% | 2.4% | −1.2 pts | −10,000 sh | −13% |
| Increased | 908 DEVICES INC (MASS) | 1.2% | 1.3% | +0.1 pts | +175K sh | +20% |
| Increased | ESTABLISHMENT LABS HLDGS INC (ESTA) | 4.8% | 4.2% | −0.6 pts | +17,926 sh | +4% |
| Increased | STEREOTAXIS INC (STXS) | 0.6% | 0.5% | −0.1 pts | +161K sh | +10% |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 57.7% of the equity book
Changes in the top 10 this quarter: ABBV entered · DXCM entered · UNH entered · ACHC entered · EVH entered · ISRG entered · CRL left · UHS left · SGRY left · RGEN left · BSX left · ESTA left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | SANOFI (SNY) | 5.6% | 9.3% | |
| 2 | ABBVIE INC (ABBV) | 0.0% | 7.4% | Entered the top 10 |
| 3 | ICON PLC (ICLR) | 7.8% | 5.9% | |
| 4 | DEXCOM INC (DXCM) | 2.4% | 5.7% | Entered the top 10 |
| 5 | UNITEDHEALTH GROUP INC (UNH) | 0.0% | 5.5% | Entered the top 10 |
| 6 | ACADIA HEALTHCARE COMPANY IN (ACHC) | 3.0% | 5.3% | Entered the top 10 |
| 7 | GILEAD SCIENCES INC (GILD) | 5.7% | 5.0% | |
| 8 | EVOLENT HEALTH INC (EVH) | 0.0% | 4.7% | Entered the top 10 |
| 9 | COOPER COS INC (COO) | 7.3% | 4.6% | |
| 10 | INTUITIVE SURGICAL INC (ISRG) | 3.3% | 4.4% | Entered the top 10 |
| — | CHARLES RIV LABS INTL INC (CRL) | 7.8% | 3.8% | Left the top 10 |
| — | UNIVERSAL HLTH SVCS INC (UHS) | 7.6% | 0.0% | Left the top 10 |
| — | SURGERY PARTNERS INC (SGRY) | 6.4% | 4.1% | Left the top 10 |
| — | REPLIGEN CORP (RGEN) | 5.4% | 0.0% | Left the top 10 |
| — | BOSTON SCIENTIFIC CORP (BSX) | 5.0% | 0.0% | Left the top 10 |
| — | ESTABLISHMENT LABS HLDGS INC (ESTA) | 4.8% | 4.2% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).